Online citations, reference lists, and bibliographies.
← Back to Search

Superparamagnetic Iron Oxide Nanoparticles For Delivery Of Therapeutic Agents: Opportunities And Challenges

S. Laurent, A. A. Saei, Shahed Behzadi, A. Panahifar, M. Mahmoudi
Published 2014 · Materials Science, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Introduction: Bearing in mind that many promising drug candidates have the problem of reaching their target site, the concept of advanced drug delivery can play a significant complementary role in shaping modern medicine. Among other nanoscale drug carriers, superparamagnetic iron oxide nanoparticles (SPIONs) have shown great potential in nanomedicine. The intrinsic properties of SPIONs, such as inherent magnetism, broad safety margin and the availability of methods for fabrication and surface engineering, pave the way for diverse biomedical applications. SPIONs can achieve the highest drug targeting efficiency among carriers, since an external magnetic field locally applied to the target organ enhances the accumulation of magnetic nanoparticles in the drug site of action. Moreover, theranostic multifunctional SPIONs make simultaneous delivery and imaging possible. In spite of these favorable qualities, there are some toxicological concerns, such as oxidative stress, unpredictable cellular responses and induction of signaling pathways, alteration in gene expression profiles and potential disturbance in iron homeostasis, that need to be carefully considered. Besides, the protein corona at the surface of the SPIONs may induce few shortcomings such as reduction of SPIONs targeting efficacy. Areas covered: In this review, we will present recent developments of SPIONs as theranostic agents. The article will further address some barriers on drug delivery using SPIONs. Expert opinion: One of the major success determinants in targeted in vivo drug delivery using SPIONs is the adequacy of magnetic gradient. This can be partially achieved by using superconducting magnets, local implantation of magnets and application of magnetic stents. Other issues that must be considered include the pharmacokinetics and in vivo fate of SPIONs, their biodegradability, biocompatibility, potential side effects and the crucial impact of protein corona on either drug release profile or mistargeting. Surface modification of SPIONs can open up the possibility of drug delivery to intracellular organelles, drug delivery across the blood–brain barrier, modifying metabolic diseases and a variety of other multimodal and/or theranostic applications.
This paper references
10.1088/0957-4484/21/41/415102
Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery.
M. Yu (2010)
10.1021/bc200151q
Theranostics: combining imaging and therapy.
Sneha S. Kelkar (2011)
10.1021/nn900330m
Size-Dependent Accumulation of PEGylated Silane-Coated Magnetic Iron Oxide Nanoparticles in Murine Tumors.
E. K. U. Larsen (2009)
Biocompatibility of Fe3O4 nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells
B Ankamwar (2010)
10.1158/0008-5472.CAN-10-1022
EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.
C. Hadjipanayis (2010)
10.1109/NMDC.2006.4388813
Preparation of Water-Dispersible and Biocompatible Iron Oxide Nanoparticles for MRI Agent
Y. Lee (2008)
10.1016/J.ACTBIO.2007.05.011
Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer: core-shell nanoparticle carrier and drug release response.
J. Zhang (2007)
10.1007/S10856-007-3130-6
Surface modified superparamagnetic iron oxide nanoparticles: as a new carrier for bio-magnetically targeted therapy
Sheng Liang (2007)
10.1148/RADIOL.2283020872
Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study.
Y. Anzai (2003)
10.1021/jp803016n
Optimal design and characterization of superparamagnetic iron oxide nanoparticles coated with polyvinyl alcohol for targeted delivery and imaging.
M. Mahmoudi (2008)
10.1016/j.biomaterials.2009.06.004
Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications.
Jia-Jyun Lin (2009)
10.2217/17435889.3.4.495
Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles.
C. Sun (2008)
10.1016/J.ADDR.2006.09.013
Recent advances in iron oxide nanocrystal technology for medical imaging.
C. Corot (2006)
10.7150/thno.4827
Multifunctional Iron Oxide Nanoparticles for Diagnostics, Therapy and Macromolecule Delivery
S. K. Yen (2013)
10.1002/smll.201303540
Zwitterionic-coated "stealth" nanoparticles for biomedical applications: recent advances in countering biomolecular corona formation and uptake by the mononuclear phagocyte system.
Karina Pombo García (2014)
10.1016/j.biomaterials.2010.11.035
Dual-aptamer-based delivery vehicle of doxorubicin to both PSMA (+) and PSMA (-) prostate cancers.
Kyoungin Min (2011)
10.1016/J.JMMM.2003.12.416
Nanoparticles of Magnetic Ferric Oxides Encapsulated with Poly(D,L Laticde-Co Glycolide) and Their Applications to Magnetic Resonance Imaging Contrast Agent.
S. J. Lee (2003)
Conjugation of functionalized SPIONs SPIONs for delivery of therapeutic agents Expert Opin. Drug Deliv
W Jiang (2012)
10.1021/NL034211O
Solvent-Free Atom Transfer Radical Polymerization in the Synthesis of Fe2O3@Polystyrene Core−Shell Nanoparticles
Y. Wang (2003)
10.1016/j.nano.2009.04.002
Multifunctional magnetic nanoparticles for targeted delivery.
A. Kumar (2010)
10.1021/nn1008512
Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma.
Forrest M Kievit (2010)
10.1002/smll.201100472
Image-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles.
M. Yu (2011)
10.1021/CM051646Z
Development of Magnetic Nanostructured Silica-Based Materials as Potential Vectors for Drug-Delivery Applications
M. Arruebo (2006)
10.2174/156720111793663642
Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes.
O. Taratula (2011)
10.1002/ADMA.200401904
Magnetite-Loaded Polymeric Micelles as Ultrasensitive Magnetic-Resonance Probes†
Hua Ai (2005)
10.1109/NMDC.2006.4388813
Preparation of Water-Dispersible and Biocompatible Iron Oxide Nanoparticles for MRI Agent
Yun Tack Lee (2006)
10.2217/nnm.12.81
Interview: An architectural journey: from trees, dendrons/dendrimers to nanomedicine. Interview by Hannah Stanwix.
D. Tomalia (2012)
10.1021/nl803054h
Gold nanoparticles can induce the formation of protein-based aggregates at physiological pH.
Dongmao Zhang (2009)
10.1016/S0304-8853(98)00584-8
Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy
S. Goodwin (1999)
10.1016/J.JMMM.2006.10.1195
Development of magnetically targeted drug delivery system using superconducting magnet
S. Takeda (2007)
10.1021/JA072210I
Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo.
Haerim Lee (2007)
10.1021/la2037845
Magnetic nanocarriers of doxorubicin coated with poly(ethylene glycol) and folic acid: relation between coating structure, surface properties, colloidal stability, and cancer cell targeting.
Karine Kaaki (2012)
Fe2O3 polystyrene core-shell nanoparticles
(2003)
10.1073/PNAS.78.1.579
Tumor remission in Yoshida sarcoma-bearing rts by selective targeting of magnetic albumin microspheres containing doxorubicin.
K. Widder (1981)
10.1016/S1054-3589(08)60246-X
Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents.
K. Widder (1979)
10.1021/nl1033733
Magnetically vectored nanocapsules for tumor penetration and remotely switchable on-demand drug release.
S. D. Kong (2010)
10.1016/j.cis.2013.10.013
Exocytosis of nanoparticles from cells: role in cellular retention and toxicity.
Ramin Sakhtianchi (2013)
10.1021/SC400042H
Adsorption of a Protein Monolayer via Hydrophobic Interactions Prevents Nanoparticle Aggregation under Harsh Environmental Conditions.
S. Domínguez-Medina (2013)
10.1016/j.colsurfb.2009.08.044
A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles.
M. Mahmoudi (2010)
10.1166/JNN.2012.5753
Effects of PEG length and iron oxide nanoparticles size on reduced protein adsorption and non-specific uptake by macrophage cells.
F. Ni (2012)
10.1021/mp100273t
Superparamagnetic iron oxide nanotheranostics for targeted cancer cell imaging and pH-dependent intracellular drug release.
P. Zou (2010)
10.1007/s11051-013-1824-x
PEGylation of SPIONs by polycondensation reactions: a new strategy to improve colloidal stability in biological media
W. R. Viali (2013)
10.1016/j.ijpharm.2010.12.046
Novel magnetic iron oxide nanoparticles coated with poly(ethylene imine)-g-poly(ethylene glycol) for potential biomedical application: synthesis, stability, cytotoxicity and MR imaging.
C. Schweiger (2011)
10.1016/j.carbpol.2012.09.098
Dextran stabilized iron oxide nanoparticles: synthesis, characterization and in vitro studies.
S. L. Easo (2013)
10.1109/TMAG.2012.2223202
Magnetically Vectored Delivery of Cancer Drug Using Remotely On–Off Switchable NanoCapsules
S. D. Kong (2013)
10.1021/nn404166q
Optimizing the properties of the protein corona surrounding nanoparticles for tuning payload release.
Anna Cifuentes-Rius (2013)
10.1016/J.TRAC.2012.09.011
Electrochemical biosensors for glucose based on metal nanoparticles
A. A. Saei (2013)
10.1021/mp200006f
HSA coated iron oxide nanoparticles as drug delivery vehicles for cancer therapy.
Qimeng Quan (2011)
10.1021/nn2021088
Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell "vision" versus physicochemical properties of nanoparticles.
M. Mahmoudi (2011)
10.1039/B617402G
Polyethyleneimine functionalized iron oxide nanoparticles as agents for DNA delivery and transfection
S. C. McBain (2007)
10.1016/J.BIOMATERIALS.2004.10.012
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
A. Gupta (2005)
10.1016/j.biomaterials.2010.03.070
Superparamagnetic iron oxide--loaded poly(lactic acid)-D-alpha-tocopherol polyethylene glycol 1000 succinate copolymer nanoparticles as MRI contrast agent.
Chandrasekharan Prashant (2010)
10.1371/journal.pone.0037376
Conjugation of Functionalized SPIONs with Transferrin for Targeting and Imaging Brain Glial Tumors in Rat Model
W. Jiang (2012)
10.1021/nl403419e
Variation of protein corona composition of gold nanoparticles following plasmonic heating.
M. Mahmoudi (2014)
10.1088/0957-4484/20/30/305101
Thermoresponsive core-shell magnetic nanoparticles for combined modalities of cancer therapy.
S. Purushotham (2009)
Superparamagnetic iron oxide--Loaded poly (lactic acid)-d-a-tocopherol polyethylene glycol 1000 succinate copolymer nanoparticles as MRI contrast agent
C Prashant (2010)
10.1039/c0nr00733a
Irreversible changes in protein conformation due to interaction with superparamagnetic iron oxide nanoparticles.
M. Mahmoudi (2011)
10.1021/bm300046h
Development of multifunctional hyaluronan-coated nanoparticles for imaging and drug delivery to cancer cells.
M. El-Dakdouki (2012)
10.1088/0957-4484/19/41/415101
Bio-functionalization of magnetite nanoparticles using an aminophosphonic acid coupling agent: new, ultradispersed, iron-oxide folate nanoconjugates for cancer-specific targeting.
M. Das (2008)
10.1021/JA052337C
In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals.
Y. Huh (2005)
10.1038/srep02173
Superparamagnetic iron oxide nanoparticles alter expression of obesity and T2D-associated risk genes in human adipocytes
S. Sharifi (2013)
10.1088/0022-3727/42/22/224002
Progress in the preparation of magnetic nanoparticles for applications in biomedicine
A. G. Roca (2009)
10.2147/IJN.S43263
Targeted therapy for human hepatic carcinoma cells using folate-functionalized polymeric micelles loaded with superparamagnetic iron oxide and sorafenib in vitro
L. Zhang (2013)
Preclinical experiences with magnetic drug targeting: tolerance and efficacy.
A. Lübbe (1996)
10.1039/c2cc17852d
Synthesis of β-cyclodextrin conjugated superparamagnetic iron oxide nanoparticles for selective binding and detection of cholesterol crystals.
Hongguang Li (2012)
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.
A. Lübbe (1996)
10.1016/j.biomaterials.2012.11.037
Superparamagnetic iron oxide and drug complex-embedded acoustic droplets for ultrasound targeted theranosis.
C. Wang (2013)
10.1088/0957-4484/24/1/015603
Preparation and in vitro evaluation of folate-receptor-targeted SPION-polymer micelle hybrids for MRI contrast enhancement in cancer imaging.
S. Mahajan (2013)
10.1186/1477-044X-2-3
Hyperthermia using magnetite cationic liposomes for hamster osteosarcoma
Fumiko Matsuoka (2004)
10.1016/j.biomaterials.2010.08.039
Multifunctional SPIO/DOX-loaded wormlike polymer vesicles for cancer therapy and MR imaging.
Xiaoqiang Yang (2010)
10.1006/JCIS.1997.5125
Thiolation of Maghemite Nanoparticles by Dimercaptosuccinic Acid
Fauconnier (1997)
10.1002/jbio.201200204
Intra-operative ex vivo photoacoustic nodal staging in a rat model using a clinical superparamagnetic iron oxide nanoparticle dispersion.
Diederik J. Grootendorst (2013)
10.1016/j.biomaterials.2013.10.029
In vivo hepatocyte MR imaging using lactose functionalized magnetoliposomes.
A. Ketkar-Atre (2014)
10.1016/j.jconrel.2011.06.001
Targeted drug delivery to tumors: myths, reality and possibility.
Y. Bae (2011)
10.1016/J.ADDR.2006.09.012
Brain cancer diagnosis and therapy with nanoplatforms.
Y. Koo (2006)
10.1016/j.colsurfb.2009.03.004
Effect of surface charge of magnetite nanoparticles on their internalization into breast cancer and umbilical vein endothelial cells.
Tetsuya Osaka (2009)
10.1039/C2RA22093H
Plasma concentration gradient influences the protein corona decoration on nanoparticles
Mahdi Ghavami (2013)
10.1016/J.IJPHARM.2007.04.036
Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics.
Susumu Nagayama (2007)
10.1039/c2cc17937g
Efficient γ-amino-proline-derived cell penetrating peptide-superparamagnetic iron oxide nanoparticle conjugates via aniline-catalyzed oxime chemistry as bimodal imaging nanoagents.
S. Cavalli (2012)
10.1158/0008-5472.CAN-10-2070
Image-guided breast tumor therapy using a small interfering RNA nanodrug.
M. Kumar (2010)
10.1109/TBME.2007.899347
Validation of High Gradient Magnetic Field Based Drug Delivery to Magnetizable Implants Under Flow
Z. G. Forbes (2008)
10.1021/tx800064j
Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes.
H. Karlsson (2008)
10.1016/j.biomaterials.2011.02.006
cRGD-functionalized, DOX-conjugated, and ⁶⁴Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging.
Xiaoqiang Yang (2011)
10.1002/mrm.10684
Noninvasive monitoring of stem cell transfer for muscle disorders
G. Walter (2004)
10.1002/SMLL.200600009
Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery.
N. Kohler (2006)
Superparamagnetic iron oxide nanoparticles: amplifying ROS stress to improve anticancer drug efficacy. Theranostics
G Huang (2013)
10.1166/JNN.2012.6379
Efficient internalization of peptide-conjugated SPIONs in dendritic cells for tumor targeting.
D. Kim (2012)
10.1016/S0927-7765(99)00156-3
'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption.
Gref (2000)
10.2147/IJN.S33709
Impact of surface coating and particle size on the uptake of small and ultrasmall superparamagnetic iron oxide nanoparticles by macrophages
S. Saito (2012)
10.1038/nnano.2012.237
Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface.
A. Salvati (2013)
10.1016/j.biomaterials.2008.09.050
The influence of protein adsorption on nanoparticle association with cultured endothelial cells.
Morton Ehrenberg (2009)
10.1002/JBM.B.30524
Preparation and magnetic resonance imaging effect of polyvinylpyrrolidone-coated iron oxide nanoparticles.
H. Lee (2006)
10.1016/J.PROGPOLYMSCI.2007.05.001
Chemical modification of chitosan as a gene carrier in vitro and in vivo
T. Kim (2007)
Solvent-free atom transfer radical polymerization in the synthesis of SPIONs for delivery of therapeutic agents Expert Opin. Drug Deliv
Y Wang (2003)
Conjugation of functionalized SPIONs SPIONs for delivery of therapeutic agents
W Jiang (2012)
10.1002/smll.200800646
Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles.
O. Veiseh (2009)
10.2214/AJR.152.1.167
Superparamagnetic iron oxide: pharmacokinetics and toxicity.
R. Weissleder (1989)
10.1016/j.biomaterials.2011.07.026
Dendronized iron oxide nanoparticles for multimodal imaging.
G. Lamanna (2011)
10.1021/nn3035155
Preventing protein adsorption and macrophage uptake of gold nanoparticles via a hydrophobic shield.
T. Larson (2012)
10.1016/J.JMMM.2012.06.045
Size-controlled synthesis of superparamagnetic iron oxide nanoparticles and their surface coating by gold for biomedical applications
H. Maleki (2012)
10.2147/IJN.S26865
Evaluation of uptake and transport of cationic and anionic ultrasmall iron oxide nanoparticles by human colon cells
Blanka Halamoda Kenzaoui (2012)
10.1007/s11671-008-9174-9
Magnetic Iron Oxide Nanoparticles: Synthesis and Surface Functionalization Strategies
W. Wu (2008)
10.1021/JP900798R
Superparamagnetic Iron Oxide Nanoparticles with Rigid Cross-linked Polyethylene Glycol Fumarate Coating for Application in Imaging and Drug Delivery
M. Mahmoudi (2009)
10.1016/J.JCONREL.2004.07.028
Pre-coating with serum albumin reduces receptor-mediated hepatic disposition of polystyrene nanosphere: implications for rational design of nanoparticles.
K. Ogawara (2004)
10.1007/S11051-005-9011-3
Iron/iron oxide core-shell nanoclusters for biomedical applications
Y. Qiang (2006)
10.1002/3527603476.CH13
Decorporation of Biohazards Utilizing Nanoscale Magnetic Carrier Systems
A. Rosengart (2005)
10.1016/J.JMMM.2005.02.040
Mathematical modelling of magnetically targeted drug delivery
A. Grief (2005)
10.1006/JCIS.2001.7579
Synthesis and Characterization of Spherical Magnetite/Biodegradable Polymer Composite Particles.
S. A. Gómez-Lopera (2001)
10.1016/j.cis.2011.04.003
Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles.
S. Laurent (2011)
10.1016/j.biomaterials.2010.11.028
Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy.
Murali M Yallapu (2011)
10.1002/ADMA.200701975
Controlled PEGylation of Monodisperse Fe3O4 Nanoparticles for Reduced Non‐Specific Uptake by Macrophage Cells
J. Xie (2007)
10.1021/cr200472g
Therapeutic benefits from nanoparticles: the potential significance of nanoscience in diseases with compromise to the blood brain barrier.
S. Krol (2013)
10.1016/j.biomaterials.2011.08.014
Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapy.
M. Hua (2011)
Crucial role of protein corona for specific targeting of nanoparticles. Nanomedicine 2014;In press
M Mahmoudi (2014)
10.3390/ma6104689
Difference between Toxicities of Iron Oxide Magnetic Nanoparticles with Various Surface-Functional Groups against Human Normal Fibroblasts and Fibrosarcoma Cells
Won Jun Yang (2013)
10.1016/j.biomaterials.2010.09.077
Multifunctional superparamagnetic nanocarriers with folate-mediated and pH-responsive targeting properties for anticancer drug delivery.
M. Guo (2011)
10.1371/journal.pone.0066416
An RGD-Modified MRI-Visible Polymeric Vector for Targeted siRNA Delivery to Hepatocellular Carcinoma in Nude Mice
Chun Wu (2013)
10.1021/JP9001516
Cytotoxicity of Uncoated and Polyvinyl Alcohol Coated Superparamagnetic Iron Oxide Nanoparticles
M. Mahmoudi (2009)
10.1016/j.nano.2011.08.017
Iron oxide nanoparticles for targeted cancer imaging and diagnostics.
Joshua E. Rosen (2012)
10.1039/c0nr00821d
Folate receptor targeted, carboxymethyl chitosan functionalized iron oxide nanoparticles: a novel ultradispersed nanoconjugates for bimodal imaging.
D. Bhattacharya (2011)
10.1021/cr068445e
Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications.
S. Laurent (2008)
10.2147/IJN.S28316
Enhanced cellular uptake of aminosilane-coated superparamagnetic iron oxide nanoparticles in mammalian cell lines
X. Zhu (2012)
10.1080/10717540903059549
Positive hyaluronan/PEI/DNA complexes as a target-specific intracellular delivery to malignant breast cancer
Xiyang Sun (2009)
10.1073/pnas.1105270108
Binding of blood proteins to carbon nanotubes reduces cytotoxicity
C. Ge (2011)
10.1039/c3cc37307j
Protein corona significantly reduces active targeting yield.
Vahid Mirshafiee (2013)
Superparamagnetic iron oxide nanoparticles with rigid crosslinked polyethylene glycol fumarate coating for application in imaging and drug delivery
M Mahmoudi (2009)
10.1016/j.nano.2008.05.004
Nanoimmunoliposome delivery of superparamagnetic iron oxide markedly enhances targeting and uptake in human cancer cells in vitro and in vivo.
Chengli Yang (2008)
Selective targeting capability acquired with a protein corona adsorbed on the surface of DOTAP/ DNA nanoparticles
G Caracciolo (2013)
10.1016/j.colsurfb.2012.09.026
On designing stable magnetic vectors as carriers for malaria DNA vaccine.
F. Al-Deen (2013)
10.1021/nn301389c
Exploiting the protein corona around gold nanorods for loading and triggered release.
J. Kah (2012)
10.1073/pnas.1111405108
Nanoparticles enhance brain delivery of blood–brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging
R. Koffie (2011)
10.1163/156856208786440451
Pluronic/chitosan shell cross-linked nanocapsules encapsulating magnetic nanoparticles
K. H. Bae (2008)
10.1002/ADEM.200990035
Cytotoxicity and Cell Cycle Effects of Bare and Poly(vinyl alcohol)‐Coated Iron Oxide Nanoparticles in Mouse Fibroblasts
M. Mahmoudi (2009)
10.1140/EPJE/I2006-10051-Y
Citric-acid-coated magnetite nanoparticles for biological applications
M. Răcuciu (2006)
10.1016/j.biotechadv.2013.11.012
Interaction of stable colloidal nanoparticles with cellular membranes.
M. Mahmoudi (2014)
10.1517/17425247.2013.772976
Nanocapsules with specific targeting and release properties using miniemulsion polymerization
K. Landfester (2013)
10.1016/J.JMMM.2005.01.080
Analysis of magnetic drug carrier particle capture by a magnetizable intravascular stent—2: Parametric study with multi-wire two-dimensional model
H. Chen (2005)
10.1021/am404171h
Selective targeting capability acquired with a protein corona adsorbed on the surface of 1,2-dioleoyl-3-trimethylammonium propane/DNA nanoparticles.
G. Caracciolo (2013)
10.1088/0957-4484/21/7/075102
Biocompatibility of Fe(3)O(4) nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells.
B. Ankamwar (2010)
10.1021/ja107583h
Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles.
M. Monopoli (2011)
10.2217/17435889.3.5.703
Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.
M. Longmire (2008)
10.2217/NNM.12.99
Erratum: Chemotherapy targeting by DNA capture in viral protein particles (Nanomedicine (2012) 7:3 (335-352))
H. Agadjanian (2012)
Superparamagnetic nanoparticles for biomedical applications
Margarethe Hoffman-Amtenbrink (2009)
10.1021/ja910675v
What the cell "sees" in bionanoscience.
Dorota Walczyk (2010)
10.1021/BC050050Z
Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments.
Fabio Sonvico (2005)
10.1007/s11064-007-9488-5
Brain Iron Toxicity: Differential Responses of Astrocytes, Neurons, and Endothelial Cells
Julie A. Gaasch (2007)
10.1039/c3nr00345k
Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles.
H. Amiri (2013)
10.1016/J.APSUSC.2011.12.054
A simplified method for synthesis of Fe3O4@PAA nanoparticles and its application for the removal of basic dyes
Yinyin Xu (2012)
10.1016/j.biomaterials.2010.07.016
Chlorotoxin bound magnetic nanovector tailored for cancer cell targeting, imaging, and siRNA delivery.
O. Veiseh (2010)
10.1016/j.addr.2010.05.006
Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy.
M. Mahmoudi (2011)
10.1002/chem.201003632
Silica nanocapsules of fluorescent conjugated polymers and superparamagnetic nanocrystals for dual-mode cellular imaging.
Happy Tan (2011)
10.3892/IJO.17.2.309
Targeted delivery of anticancer drugs with intravenously administered magnetic liposomes in osteosarcoma-bearing hamsters.
T. Kubo (2000)
10.1021/LA0503451
Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells.
N. Kohler (2005)
10.1016/j.eururo.2008.12.034
Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients.
H. Thoeny (2009)
10.1021/JA061529K
Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging.
Haerim Lee (2006)
10.1021/nn205070h
Targeting of primary breast cancers and metastases in a transgenic mouse model using rationally designed multifunctional SPIONs.
Forrest M Kievit (2012)
10.3311/PPCH.7285
Colloidal stability of carboxylated iron oxide nanomagnets for biomedical use
Etelka Tombácz (2014)
10.1016/J.COLSURFA.2007.04.172
Magnetic and MR relaxation properties of avidin-biotin conjugated superparamagnetic nanoparticles
J. Park (2008)
10.1016/j.biomaterials.2008.12.043
MRI-visible polymeric vector bearing CD3 single chain antibody for gene delivery to T cells for immunosuppression.
Gui-Hua Chen (2009)
10.7150/thno.5411
Superparamagnetic Iron Oxide Nanoparticles: Amplifying ROS Stress to Improve Anticancer Drug Efficacy
G. Huang (2013)
Rotavirus capsid surface protein VP4-coated Fe3O4 nanoparticles as a theranostic platform for cellular imaging and drug delivery. Biomaterials
W Chen (2012)
10.1002/cmdc.200800091
Superparamagnetic Iron Oxide Nanoparticle–Aptamer Bioconjugates for Combined Prostate Cancer Imaging and Therapy
A. Wang (2008)
10.1021/cr1001832
Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine.
M. Mahmoudi (2011)
10.1021/nn101000e
Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: a multifunctional nanocarrier system for cancer diagnosis and treatment.
Hoonsung Cho (2010)
10.1038/nbt1340
Renal clearance of quantum dots
H. Choi (2007)
10.1166/JBN.2005.027
Targeting Breast Cancer Cells and Their Metastases Through Luteinizing Hormone Releasing Hormone (LHRH) Receptors Using Magnetic Nanoparticles
C. Leuschner (2005)
10.1002/JPS.21249
Magnetic colloids as drug vehicles.
J. D. Durán (2008)
10.1039/c2nr11554a
Accumulation of magnetic iron oxide nanoparticles coated with variably sized polyethylene glycol in murine tumors.
E. K. U. Larsen (2012)
10.1016/j.biomaterials.2012.07.016
Rotavirus capsid surface protein VP4-coated Fe(3)O(4) nanoparticles as a theranostic platform for cellular imaging and drug delivery.
W. Chen (2012)
10.1016/j.biomaterials.2010.02.068
Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer.
Jin Hee Maeng (2010)
10.1021/nn101670k
Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging.
Xiaoqiang Yang (2010)
10.3109/02652049609026013
Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution.
C. Chouly (1996)
10.2217/nnm.14.69
Crucial role of the protein corona for the specific targeting of nanoparticles.
M. Mahmoudi (2015)
10.1158/0008-5472.CAN-06-1668
Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner.
Chunfu Zhang (2007)
10.1021/mp7001285
Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats.
Tapan Jain (2008)
An RGDmodified MRI-visible polymeric vector for targeted siRNA delivery to hepatocellular carcinoma in nude mice
C Wu (2013)



This paper is referenced by
10.1016/j.msec.2016.09.052
Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Yinping Huang (2017)
10.1016/j.msec.2016.04.029
Acid and reduction stimulated logic "and"-type combinational release mode achieved in DOX-loaded superparamagnetic nanogel.
Meifang Song (2016)
10.5772/intechopen.85035
Poly(L-Lactide) Bionanocomposites
A. N. Chakoli (2019)
10.1088/1361-6463/AB03C0
Magnetic particle spectroscopy-based bioassays: methods, applications, advances, and future opportunities
K. Wu (2019)
10.1016/j.nano.2015.10.019
Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: Possibilities and challenges.
Zahra Bakhtiary (2016)
Nanoparticules lipidiques de type Janus à compartiment superparamagnétique : du procédé de mise en oeuvre aux applications théranostiques
E. Millart (2017)
10.3390/medicina55070388
Synthesis of Nano-Paramagnetic Oleuropein to Induce KRAS Over-Expression: A New Mechanism to Inhibit AGS Cancer Cells
Farhad Barzegar (2019)
10.1149/2.0231505JSS
Assessment of Magnetic Properties of Nanostructured Silicon Loaded with Superparamagnetic Iron Oxide Nanoparticles
P. Granitzer (2015)
10.3390/ijms161023784
Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems
F. Jiang (2015)
10.1016/B978-0-08-101914-6.00008-9
Nanoparticles for tumor targeting
Ting Jiang (2017)
10.1088/0031-9155/61/11/3986
Magnetic particle spectroscopy allows precise quantification of nanoparticles after passage through human brain microvascular endothelial cells.
C. Gräfe (2016)
10.1016/j.aquatox.2015.12.013
Toxicity assessment and comparison between two types of iron oxide nanoparticles in Mytilus galloprovincialis.
Chrysa Taze (2016)
10.1016/j.jconrel.2014.07.059
Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapy.
N. Schleich (2014)
10.1007/s12272-020-01206-5
Principles and applications of nanomaterial-based hyperthermia in cancer therapy
Jin Kook Kang (2020)
10.2217/nnm.15.159
Nanomedical innovation: the SEON-concept for an improved cancer therapy with magnetic nanoparticles.
S. Lyer (2015)
10.1039/c9dt00459a
Superparamagnetic iron oxide nanoparticulate system: synthesis, targeting, drug delivery and therapy in cancer.
Sathyadevi Palanisamy (2019)
10.1016/J.TRAC.2019.03.004
Application and development of superparamagnetic nanoparticles in sample pretreatment and immunochromatographic assay
Z. Huang (2019)
10.2147/IJN.S122580
In vitro toxicity of FemOn, FemOn-SiO2 composite, and SiO2-FemOn core-shell magnetic nanoparticles
Y. Toropova (2017)
10.1088/1361-6463/ab7bb2
Magnetic drug-loaded osteoinductive Fe3O4/CaCO3 hybrid microspheres system: efficient for sustained release of antibiotics
Jingyi Xue (2020)
10.1016/J.PARTIC.2016.06.001
Magnetic nanoparticles for environmental and biomedical applications: A review
L. Mohammed (2017)
10.1039/C5NJ02441B
Superparamagnetic Fe3O4 nanoparticles: synthesis by a solvothermal process and functionalization for a magnetic targeted curcumin delivery system
M. Qi (2016)
10.1007/s12274-017-1540-4
Folate targeted coated SPIONs as efficient tool for MRI
C. Scialabba (2017)
10.4236/ns.2019.103008
Zinc Oxide Composites of Doxorubicin in the Form of Coating , Composite Films and Gels with a High Antitumor Activity and Low Toxicity
E. R. Arakelova (2019)
10.1016/j.msec.2016.10.008
Pegylated and amphiphilic Chitosan coated manganese ferrite nanoparticles for pH-sensitive delivery of methotrexate: Synthesis and characterization.
Z. Karimi (2017)
10.1039/C7RA12862B
Novel morphologies of poly(allyamine hydrochloride)–methotrexate nanoassemblies for methotrexate delivery
W. Wang (2018)
10.1007/s13738-018-1355-6
Magnetic molecularly imprinted polymer nanoparticles for dispersive micro solid-phase extraction and determination of buprenorphine in human urine samples by HPLC-FL
B. Habibi (2018)
10.1016/B978-0-323-47347-7.00027-6
Multifunctional Magnetic Liposomes for Cancer Imaging and Therapeutic Applications
Manashjit Gogoi (2016)
10.1007/s00604-020-04454-w
Accurate iron quantification in colloids and nanocomposites by a simple UV-Vis protocol
Miquel Torras (2020)
10.25673/13448
Processing and characterization of tailor-made superparamagnetic iron oxide nanoparticles (SPIO-NPs) for pharmaceutical applications
M. K. Khalid (2018)
10.1088/0268-1242/31/1/014004
Filling of porous silicon with magnetic materials
P. Granitzer (2016)
10.1007/978-3-030-44925-4_3
Applications of Iron Oxide Nanoparticles in the Magnetic Resonance Imaging for the Cancer Diagnosis
Kanwal Akhtar (2021)
10.3389/fbioe.2020.00325
State-of-Art Bio-Assay Systems and Electrochemical Approaches for Nanotoxicity Assessment
R. Shinde (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar